Reported 12 days ago
Michael Mager, CEO of Precision Neuroscience, discusses the potential of their brain-computer interface (BCI) to significantly improve the lives of severely paralyzed patients. Their device, the Layer 7 Cortical Interface, features a minimally invasive design and aims to connect users to the digital world without high risks associated with traditional implants. With growing support and expected FDA clearance, Precision hopes to expand its reach to thousands of patients, differentiating its mission from Neuralink's broader enhancement goals.
Source: YAHOO